T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Dutch Bros
BROS
$8.26B
| $219K | ﹤0.01% |
7,000
-1,017,255
| -99% | -$31.8M |
|
2502
Core & Main
CNM
$9.21B
| $218K | ﹤0.01% |
+9,581
| New | +$218K |
|
2503
Customers Bancorp
CUBI
$2.35B
| $217K | ﹤0.01% |
7,337
-3,446
| -32% | -$102K |
|
|
ORC
2504
Orchid Island Capital
ORC
$951M
| $216K | ﹤0.01% |
26,273
+2,125
| +9% | +$17.5K |
|
2505
uniQure
QURE
$959M
| $216K | ﹤0.01% |
11,500
-464,417
| -98% | -$8.72M |
|
2506
Anika Therapeutics
ANIK
$121M
| $215K | ﹤0.01% |
+8,998
| New | +$215K |
|
2507
Cardlytics
CDLX
$49.8M
| $214K | ﹤0.01% |
22,750
+5,170
| +29% | +$48.6K |
|
2508
Invesco Mortgage Capital
IVR
$515M
| $214K | ﹤0.01% |
19,219
+2,055
| +12% | +$22.9K |
|
2509
Universal Technical Institute
UTI
$1.48B
| $214K | ﹤0.01% |
39,207
+2,317
| +6% | +$12.6K |
|
2510
Lemonade
LMND
$3.63B
| $213K | ﹤0.01% |
+10,025
| New | +$213K |
|
2511
PMV Pharmaceuticals
PMVP
$67.3M
| $213K | ﹤0.01% |
17,864
+2,251
| +14% | +$26.8K |
|
2512
ZipRecruiter
ZIP
$404M
| $213K | ﹤0.01% |
+12,886
| New | +$213K |
|
|
CTIC
2513
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $210K | ﹤0.01% |
35,939
+6,900
| +24% | +$40.3K |
|
2514
Driven Brands
DRVN
$3B
| $208K | ﹤0.01% |
+7,425
| New | +$208K |
|
2515
Ecovyst
ECVT
$1.05B
| $208K | ﹤0.01% |
24,555
+5,969
| +32% | +$50.6K |
|
2516
IDT Corp
IDT
$1.62B
| $208K | ﹤0.01% |
+8,338
| New | +$208K |
|
2517
Vuzix
VUZI
$176M
| $208K | ﹤0.01% |
35,907
+6,859
| +24% | +$39.7K |
|
|
MODN
2518
DELISTED
MODEL N, INC.
MODN
| $208K | ﹤0.01% |
+6,064
| New | +$208K |
|
2519
Hayward Holdings
HAYW
$3.4B
| $207K | ﹤0.01% |
23,262
-647,284
| -97% | -$5.76M |
|
2520
Inovio Pharmaceuticals
INO
$140M
| $207K | ﹤0.01% |
9,956
-751
| -7% | -$15.6K |
|
2521
Kezar Life Sciences
KZR
$29.3M
| $207K | ﹤0.01% |
2,396
+862
| +56% | +$74.5K |
|
2522
Forestar Group
FOR
$1.4B
| $206K | ﹤0.01% |
18,397
+2,942
| +19% | +$32.9K |
|
2523
Vaxcyte
PCVX
$4.15B
| $206K | ﹤0.01% |
8,551
-5,377
| -39% | -$130K |
|
|
MNRL
2524
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $205K | ﹤0.01% |
+8,293
| New | +$205K |
|
2525
Triumph Financial, Inc.
TFIN
$1.42B
| $204K | ﹤0.01% |
+3,737
| New | +$204K |
|